Nanotechnology is a rapidly expanding field and have been potentially used in a wide assortment of commercial products worldwide. Silver nanoparticles (SNPs) have attracted specific attention due to their potential use in a range of applications, such as electronics, biosensing, clothing manufacture, food storage, paints, sunscreens, cosmetics and medical devices ([@B1]). SNPs have also a potent antibacterial and antifungal activity and general anti-inflammatory effects. Furthermore, SNPs can improve wound healing and may be exploited to develop dressings for wounds and burns and antibacterial coatings on medical devices to reduce nosocomial infection rates ([@B1], [@B5]).

Although ultraviolet irradiation, aerosol technologies, lithography, laser ablation, ultrasonic fields and photochemical reduction techniques have been used successfully to produce nanoparticles, they remain expensive and involve the use of hazardous chemicals ([@B25]). Therefore, there is a growing effort to develop environmentally friendly methods for nanoparticle production. The microbial synthesis of nanoparticles is a prime candidate approach because it is a green chemistry method that combines nanotechnology and microbial biotechnology ([@B25]). Some microorganisms, including bacteria, yeast and filamentous fungi play an important role in the remediation of toxic metals through the reduction of the metal ions; therefore, these microorganisms could be employed as nanofactories for nanoparticle production ([@B11]). Several studies have shown that metal nanoparticles, such as gold, silver, gold-silver alloy, selenium, tellurium, platinum, palladium, silica, titanium, zirconium, quantum dots and magnetite can be biosynthesised by bacteria, actinomycetes, fungi and viruses \[revised by [@B25]\].

The fungus *Fusarium oxysporum* can reduce aqueous silver ions extracellularly to generate SNPs ([@B2]). This process likely occurs through the action of both reductase enzymes and electron shuttle quinones ([@B10]). In addition, biological nanoparticle synthesis often yields a more consistent size distribution pattern than other methods due to direct stabilisation of the nanoparticles by proteins involved in the synthesis process, as described by [@B10].

*Fusarium* spp are filamentous fungi that are widely distributed in soil, water, subterranean and aerial plant parts, plant debris and other organic substrates ([@B26]). The widespread distribution of *Fusarium* spp is attributed to their ability to grow on a wide range of substrates and their efficient dispersal mechanisms ([@B4]). Most species are harmless saprobes and members of the soil microbial community; however, many species are mycotoxin producers and are pathogenic to plants and humans.

In the present paper, we investigate the kinetics of SNPs production using an environmentally friendly method of extracellular biosynthesis by *F. oxysporum*. The characteristics and stability of the SNPs were evaluated by electron and atomic force microscopy and the antifungal activity against pathogenic species of *Candida* and *Cryptococcus* was evaluated by broth microdilution and agar diffusion tests.

MATERIALS AND METHODS
=====================

*Fungal strains -* The *F. oxysporum* 07 SD strain was kindly provided by Elisa Espósito (Center for Environmental Sciences, University of Mogi das Cruzes, Mogi das Cruzes, state of São Paulo, Brazil). The fungus was cultivated and maintained on potato dextrose agar (PDA) (Becton & Dickinson and Company, USA) at 28ºC in Petri dishes.

The following strains of *Candida* spp and *Cryptococcu* s spp were used to evaluate the antifungal activity of the SNPs: *Candida albicans* ATCC 10231, *C. albicans* ATCC 24433, *Candida krusei* ATCC 6258, *Candida glabrata* ATCC 2001, *Candida parapsilosis* ATCC 22019, *Candida tropicalis* ATCC 13803, *Cryptococcus neofor- mans* ATCC 28957 and *Cryptococcus gattii* ATCC 56990. The yeasts were maintained on Sabouraud dextrose agar (SDA) (Becton & Dickinson) at 4ºC and subcultured at least twice on the same medium at 35ºC for 48 h prior to use in experiments to ensure optimal growth.

*SNP production - F. oxysporum* previously grown on PDA at 28ºC was inoculated in medium containing 2% malt extract and 0.5% yeast extract and incubated at 28ºC for 7 days with agitation. Subsequently, the biomass was centrifuged, washed three times with sterile water and weighed. Approximately 10 g of *F. oxysporum* biomass was added to a glass Erlenmeyer flask containing 100 mL distilled water and incubated for 72 h at 28ºC with agitation. Then, the components of the fungal aqueous extract were obtained by filtration through a 0.45 µm pore size nylon membrane filter and a silver nitrate (AgNO ~3~) solution was added to produce different concentrations of silver ions (0.5 mM, 1.0 mM, 1.5 mM and 2.0 mM). The solutions were kept up to 60 days at room temperature in the dark. Periodically, aliquots of the reaction solutions were removed and the absorption was measured from 200-600 nm with a spectrophotometer (SpectraMax M2e, Molecular Devices, Sunnyvale, CA, USA). The aliquots were also characterised using microscopy methods as follows.

*SNP characterisation - Transmission electron microscopy (TEM)* - A drop of SNP colloidal solution obtained from a 1.0 mM AgNO ~3~ solution collected at various times (5, 10, 15, 30 and 60 days) was directly dispensed on a copper grid (300 mesh) coated with polyvinyl resin (FormVar, Ted Pella, Inc) and dried in a vacuum desiccator. Images of the SNPs were obtained with a Jeol 1200 electron microscope (Jeol, Tokyo, Japan) equipped with a CCD Camera (MegaView III model, Soft Image System, Germany) and processed with iTEM software (Soft Image System). Routines were performed following the guidelines established by National Institute of Standards and Technology (NIST) for size characterisation by microscopy-based techniques ([@B15]). The SNPs size was measured using the software ImageJ \[National Institutes of Health (NIH), USA\] (rsb.info.nih.gov/ij/) from several images obtained by TEM. For elemental analysis, energy dispersive X-ray spectroscopy (EDX) was performed. Briefly, X-rays were collected using a lithium-drifet silicon detector with a Norvar window in a 0-10 keV energy range with a resolution of 10 eV/channel.

*Scanning electron microscopy (SEM)* - A drop of SNP colloidal solution obtained from a 1.0 mM AgNO ~3~ solution at various days of incubation (5, 10, 15, 30 and 60 days) was directly adhered to coverslips coated with FormVar and subsequently recovered by a carbon strip. The nanoparticles were analysed by a backscattered electron detector with a QUANTA 250 scanning electron microscope (FEI Company, Tokyo, Japan) operating at high vacuum mode.

*Atomic force microscopy* - A 10 µL aliquot of SNP colloidal solution obtained from a 1.0 mM AgNO ~3~ solution at various times (5, 10, 15, 30 and 60 days) was spread onto freshly cleaved 1 cm ^2^ mica slides and dried with a low pressure jet of nitrogen gas. Next, the SNPs on the slide were examined by an MFP-3D-BIO system (Asylum Research, Santa Barbara, CA, USA) operating in intermittent contact mode using a cantilever Olympus AC240TS. SNP size analyses were quantified and diameter size measured with the package particle analysis function in ImageJ (NIH) using several SNPs images according to standards established by NIST ( [@B15] ).

*Antifungal activity assay -* The in vitro antifungal activity of the SNPs was evaluated using the disk difusion method (CLSI 2004) with some modifications. This assay was used to test SNPs formed with different concentrations of AgNO ~3~ solutions and at different time points after the start of the reaction. Briefly, Müller-Hinton agar (Becton, Dickinson and Company) Petri plates (4 mm of depth) were prepared and, subsequently, 100 µL of fungal inoculum \[1-5 x 10 ^6^ colony-forming unit (CFU)/mL\] was uniformly spread onto the plates. Then, a 5 µL aliquot of SNP colloidal solution was impregnated on Whatman No. 1 sterile filter paper discs (5 mm in diameter). The discs were applied to the plates, which were then incubated at 35ºC for 24-48 h. Finally, the inhibition halo was measured. Water and aqueous fungal extract were used as negative controls for antifungal activity.

In addition, the antifungal activity of the SNP colloidal solution obtained from a 30-day reaction with 1.0 mM AgNO ~3~ solution was evaluated by the broth microdilution method (CLSI 2008). Briefly, the SNPs were serially diluted two-fold in RPMI-1640 medium without sodium bicarbonate (Sigma Chemical Co, MO, USA) buffered with 0.165 M MOPS (Sigma Chemical Co) in 96-well microtitre trays to obtain concentrations of 0.1 to 54 µg/mL. A fungal suspension of 1-5 x 10 ^3^ CFU/mL was prepared and 100 µL was dispensed into each well to obtain final concentrations of 0.5-2.5 x 10 ^3^ CFU/mL. The microtitre trays were incubated at 35ºC for 48 h (*Candida* spp) or 72 h (*Cryptococcus* spp) in a humidified chamber. The minimum inhibitory concentration (MIC) was the lowest concentration of SNPs that resulted in visual inhibition of fungal growth.

The determination of the minimum fungicidal concentration (MFC) was performed after 48 h of treatment with the inhibitory concentrations used in the broth microdilution assay. An aliquot of all treatments were transferred onto SDA plates without the presence of drugs. The plates were incubated at 35ºC for 48 h and the MFC was determined. MFC means the lower concentration which showed no fungal growth.

*Morphological alterations - C. neoformans* ATCC 28957 yeasts were selected for the following experiments due to higher antifungal susceptibility presenting the lowest SNPs MIC and MFC values. Yeasts were treated with a sub-inhibitory concentration (0.21 µg/mL) of SNPs, for 72 h at 35ºC, were washed in PBS, pH 7.2 and fixed in 2.5% glutaraldehyde and 4% paraformaldehyde in 0.1 M cacodylate buffer. Then, the yeasts were post-fixed in 1% osmium tetroxide in cacodylate buffer containing 1.25% potassium ferrocyanide and 5 mM CaCl ~2~ for 2 h and serially dehydrated in ethanol. Subsequently, the yeasts were embedded in Spurr's epoxy resin and ultra-thin sections were obtained using a Reichert-Jung Ultracut (Leica Microsystems, Wetzlar, Germany). Finally, the sections were stained with 5% uranyl acetate and 0.5% lead citrate and visualised on a Jeol 1200 electron microscope.

*Statistical analysis -* Statistical analyses were performed using Prism 5.0. One-way ANOVA (Dunnett's test) was utilised to compare the SNP production from different silver concentrations and Student's *t* test was used to analyse the SNP size. Samples were considered statistically significant when p \< 0.05.

RESULTS
=======

*SNP production -* The production of SNPs was initially evaluated visually for up to 60 days during the reaction of silver ions and aqueous extracts from *F. oxysporum*. Darkening of the medium colour occurred during the 60 days of the reaction for different silver ion concentrations compared to aqueous extract from *F. oxysporum* without AgNO ~3~ solution and sterile distilled water. The darkening of the colloidal solution occurred in a time-dependent manner for the first five days of the reaction; after five days, the colour remained constant until 60 days (data not shown). These colour changes are related to the reduction of silver ions that occurs during the production of SNPs. At all this reaction times, the colour of the colloidal solutions became darker in a dose-dependent manner until the concentration of 1.5 mM AgNO ~3~. SNP production was quantitatively measured by spectrophotometry. SNPs exhibited the highest absorbance between 340-560 nm, with an absorption peak at 440 nm, for all AgNO ~3~ concentrations used and reaction times tested ([Fig. 1](#f01){ref-type="fig"}). [Fig. 2](#f02){ref-type="fig"} shows that SNP production proceed the fastest rate from zero-three days; production continued to increase up to 30 days and decrease between 30-60 days. Furthermore, SNP production increased dose-dependently way to the silver ion concentration added to the reaction ([Fig. 2](#f02){ref-type="fig"}). Significantly fewer SNPs were produced from the 0.5 mM solution, as evaluated by absorbance at 440 nm, than from ion silver concentrations above 1 mM (p \< 0.01, one-way ANOVA); this difference was most striking on the third day of the reactions (p \< 0.001, one-way ANOVA). Interestingly, there was no statistically significant difference in SNP production at concentrations above 1 mM AgNO ~3~. For this reason, we used 1 mM AgNO ~3~ solutions for SNP production in the following experiments characterising SNPs.

![absorption spectrum from 20-600 nm of silver nanoparticles produced by aqueous extracts of *Fusarium oxysporum* and several concentrations of silver nitrate (AgNO ~3~) solutions at different times (0-60 days) after initiation of the reaction. A: 0.5 mM AgNO ~3~; B: 1.0 mM AgNO ~3~; C: 1.5 mM AgNO ~3~ ; D: 2.0 mM AgNO ~3~.](0074-0276-mioc-109-02-00220-gf01){#f01}

![extracellular silver nanoparticles (SNPs) production by silver nitrate solutions mixed with aqueous extract from *Fusarium oxysporum* over time (up to 60 days). The absorption of the SNPs was measured at 440 nm. \*: p \< 0.05; \*\*: p \< 0.01.](0074-0276-mioc-109-02-00220-gf02){#f02}

*SNPs characterisation -* Several microscopy techniques were used to confirm SNP production, identify the presence of silver atoms and analyze SNP size and morphology. TEM micrographs of five days SNPs revealed the presence of spherical electron-dense nanoparticles that were frequently monodispersed and relatively homogeneous in size, with variations in diameter from 3.4-26.8 nm ([Fig. 3A](#f03){ref-type="fig"}, [Table I](#t01){ref-type="table"}). Maximum SNP diameter (64.9 nm) was observed on the 30th day ([Fig. 3B](#f03){ref-type="fig"}, [Table I](#t01){ref-type="table"}).

![transmission electron microscopy characterisation of silver nanoparticles produced during different reaction periods. A: five days; B: 30 days; C: 60 days. Bars = 200 nm; D: the presence of silver atoms (black arrow) was confirmed by energy-dispersive X-ray spectroscopy; Ag: silver; C: carbon; Cu: copper; O: oxygen; P: phosphorus; S: sulphur; Si: silicon.](0074-0276-mioc-109-02-00220-gf03){#f03}

###### Diameters of silver nanoparticles (SNPs) produced from 1.0 mM silver nitrate in aqueous extracts of *Fusarium oxysporum* at different reaction times

  ---------------------- ------------------- -------------
  Reaction time (days)   SNP diameter (nm)   
                                             
  Range                  X ± SD              
                                             
  5                      3.4-26.8            13.2 ± 4.2
  10                     4.8-56.6            21.5 ± 9.1
  15                     3.2-45.5            13.5 ± 7.6
  30                     4.8-64.9            27.3 ± 12.4
  60                     1.9-53.6            10.4 ± 10.1
  ---------------------- ------------------- -------------

SD: standard deviation; X: average.

After 60 days of reaction, we observed needle-shaped nanoparticles in addition to the spherical form previously observed. In addition, the spherical SNP diameter was very heterogeneous varying from 1.9-53.6 nm ([Fig. 3C](#f03){ref-type="fig"}, [Table I](#t01){ref-type="table"}). There was observed a significant difference in SNP size between all reactions times examined (p \< 0.01), except between five-15 days. However, it is important to note that at five days, the SNPs were more homogeneous in size than in 15 days and generally more homogenous dispersed from each other. The presence of silver atoms in the colloidal solution was confirmed by EDX (black arrow in [Fig. 3D](#f03){ref-type="fig"}).

Morphological analysis by AFM revealed two distinct structural arrangements of SNPs: one of 300 ± 57 nm and another of 77 ± 30 nm ([Fig. 4B](#f04){ref-type="fig"}). The smaller structures observed by AFM include the spherical electron-dense SNPs observed by TEM. The AFM images demonstrate that the particle sizes are homogeneously distributed over the mica. In addition, medium-sized (50 nm) SNPs were detected by SEM with a backscattered electron detector ([Fig. 4A](#f04){ref-type="fig"}). We also observed an amorphous material surrounding some groups of nanoparticles.

![microscopic characterisation of silver nanoparticles (SNPs) produced by aqueous extracts of *Fusarium oxysporum* and 1.0 mM silver nitrate over five days. A: the presence of metallic particles was detected by scanning electron microscopy; B: the SNPS size and depth are indicated by the colour scale at the side of the atomic force microscopy micrograph.](0074-0276-mioc-109-02-00220-gf04){#f04}

*Antifungal activity -* All *Candida* species tested were susceptible to the SNPs produced from AgNO ~3~ solutions with concentrations above 1 mM. The results from the agar diffusion method revealed that the inhibition halo diameter was similar for SNPs collected between five-60 days of reaction ([Table II](#t02){ref-type="table"}). Among *Candida* species, *C. albicans* ATCC 10231 was the most susceptible to SNPs, as indicated by a growth inhibition halo of 13 mm when incubated with SNPs produced from 1 mM AgNO ~3~ (\~0.54 µg). By contrast, *C. krusei* ATCC 2001 and *C. tropicalis* ATCC 13803 were less susceptible to SNPs. Similar patterns of growth inhibition were observed for the *Cryptococcus* species ([Table II](#t02){ref-type="table"}).

###### Growth inhibition halos (mm) of *Candida* spp and *Cryptococcus* spp after 48 h of incubation in contact with a paper disc impregnated with silver nanoparticle colloidal solutions produced from different concentrations of silver nitrate (AgNO ~3~) with different reaction times

  ---------------------- ----------------------------- --------------------------------- -------------------------- ------------------------------------ ----------------------------------- ---------------------------- ------------------------------ -------------------------------------- ----------------------------------
  Reaction time (days)   AgNO ~3~ concentration (mM)   *Candida* *albicans* ATCC 10231   *C. albicans* ATCC 24433   *Candida* *parapsilosis* ATCC22019   *Candida* *tropicalis* ATCC 13803   *Candida krusei* ATCC 6258   *Candida glabrata* ATCC 2001   *Cryptococcus neoformans* ATCC 28957   *Cryptococcus gattii* ATCC 56990
                                                                                                                                                                                                                                                                                                
  5                      0.5                           0                                 0                          0                                    0                                   0                            0                              0                                      0
                         1.0                           13                                10                         0                                    0                                   0                            8                              8                                      8
                         1.5                           11                                10                         10                                   0                                   0                            8                              8                                      8
                         2.0                           11                                12                         12                                   0                                   7                            8                              8                                      8
  10                     0.5                           0                                 0                          0                                    0                                   0                            0                              0                                      0
                         1.0                           10                                9                          0                                    0                                   0                            8                              8                                      8
                         1.5                           11                                12                         10                                   0                                   0                            8                              8                                      8
                         2.0                           14                                12                         12                                   0                                   9                            9                              8                                      8
  15                     0.5                           0                                 0                          0                                    0                                   0                            0                              0                                      0
                         1.0                           10                                10                         9                                    0                                   0                            8                              8                                      8
                         1.5                           13                                11                         10                                   0                                   10                           9                              8                                      8
                         2.0                           13                                10                         12                                   0                                   10                           9                              9                                      9
  30                     0.5                           0                                 0                          0                                    0                                   0                            0                              0                                      0
                         1.0                           10                                10                         9                                    0                                   0                            7                              8                                      8
                         1.5                           10                                11                         11                                   0                                   9                            8                              8                                      8
                         2.0                           12                                12                         11                                   0                                   10                           8                              9                                      8
  60                     0.5                           0                                 0                          0                                    0                                   0                            8                              0                                      0
                         1.0                           10                                10                         9                                    10                                  0                            10                             10                                     8
                         1.5                           10                                10                         10                                   10                                  9                            10                             11                                     8
                         2.0                           11                                11                         10                                   10                                  10                           15                             11                                     8
  ---------------------- ----------------------------- --------------------------------- -------------------------- ------------------------------------ ----------------------------------- ---------------------------- ------------------------------ -------------------------------------- ----------------------------------

The broth microdilution method revealed that the *Cryptococcus* species were slightly more susceptible to SNP treatment (MICs from 0.42-0.84 µg/mL) than the *Candida* species (MICs from 0.84-1.68 µg/mL) ([Table III](#t03){ref-type="table"}). In addition, SNPs exhibited fungicidal activity (with MFC values up to 4 times the MIC value) against most of the species tested, with the exception of *C. parapsilosis* ATCC 22019 and *C. krusei* ATCC 6258 ([Table III](#t03){ref-type="table"}). These results are in agreement with those obtained using the agar diffusion method.

###### Minimum inhibitory concentration (MIC) and minimum fungicidal concentration (MFC) of silver nanoparticles (SNPs) for *Candida* spp and *Cryptococcus* spp concentrations

  -------------------------------------- ------------- ------------- ---------
  Strains                                MIC (µg/mL)   MFC (µg/mL)   MFC/MIC
                                                                     
  *Cryptococcus neoformans* ATCC 28957   0.42          0.42          1
  *Cryptococcus gattii* ATCC 56990       0.84          0.84          1
  *Candida glabrata* ATCC 2001           1.68          1.68          1
  *Candida albicans* ATCC 10231          1.68          3.4           2
  *C. albicans* ATCC 24433               1.68          3.4           2
  *Candida tropicalis* ATCC 13803        1.68          3.4           2
  *Candida krusei* ATCC 6258             0.84          13            15
  *Candida parapsilosis* ATCC 22019      0.84          13            15
  -------------------------------------- ------------- ------------- ---------

*Morphological alterations of C. neoformans treated with SNPs* - Untreated *C. neoformans* ATCC 28957 yeasts exhibited a well-preserved cellular ultrastructure with a compact cell wall (CW), continuous cytoplasmic membrane, homogeneous and electron-dense cytoplasm and polysaccharide capsule ([Fig. 5A](#f05){ref-type="fig"}, [B](#f05){ref-type="fig"}). By contrast, yeasts treated with sub-inhibitory concentrations of SNPs (0.21 μg/mL), for 72 h at 35ºC, exhibited a disrupted CW and several invaginations in the cytoplasmic membrane ([Fig. 5C](#f05){ref-type="fig"}, [D](#f05){ref-type="fig"}). In addition, increased CW thickness was observed ([Fig. 5E](#f05){ref-type="fig"}, [F](#f05){ref-type="fig"}). Interestingly, some SNPs appear to be retained in the fungal capsule (black arrowhead in [Fig. 5F](#f05){ref-type="fig"}).

![morphological alterations of *Cryptococcus neoformans* treated with sub-inhibitory concentrations of silver nanoparticles (SNPs) (0.21 µg/mL) for 72 h at 35ºC. The untreated yeast exhibit a compact cell wall (CW), continuous cytoplasmic membrane (cm), homogeneous and electron-dense cytoplasm and a polysaccharide capsule (c) surrounding the cell (A, B). By contrast, yeasts treated with SNPs had a disrupted cytoplasmic membrane and CW (asterisk) and increased cell wall thickness (CW) (C, D). The SNPs appear to be retained in the polysaccharide capsule (F, black arrowhead).](0074-0276-mioc-109-02-00220-gf05){#f05}

DISCUSSION
==========

In the last decade, the development of biological systems as an environmentally friendly method for metal nanoparticle formation has emerged as an interesting and important scientific field. A wide number of microorganisms, including bacteria, yeast, filamentous fungi, algae and plants, have been shown to be capable of fabricating various types of metal nanoparticles like silver, gold, palladium and others ([@B28]).

Previous studies have demonstrated that filamentous fungi, such as *F. oxysporum* ([@B10]), *Fusarium accuminatum* ([@B14]), *Aspergillus niger* ([@B12]), *Amylomyces rouxii* ([@B24]) and the endophytic fungus *Epicoccum nigrum* ([@B27]) are most efficient at producing SNPs. However, the majority of these studies used only a single concentration of AgNO ~3~ solution (1.0 mM) to produce SNPs. Our work further characterises the production of SNPs by a green synthesis method using aqueous extracts of *F. oxysporum* and different silver concentrations for up to 60 days. Spectrophotometric analyses revealed that concentrations below 1 mM AgNO ~3~ produced fewer SNPs than concentrations ≥ 1 mM AgNO ~3~ . Interestingly, the use of concentrations \> 1.0 mM did not result in increased SNP production. With respect to the kinetics of SNP production, we found that increasing amounts of SNPs were produced for the first 30 days, followed by a decrease in production after 60 days. This finding indicates that the SNPs likely began to degrade after a prolonged incubation time. These changes in SNP production rates correlated with the appearance of needle-shaped SNPs, in addition to the previously observed spherical forms, on day 60 of the reactions. SNPs sizes could range from 1-100 nm and are characterised by a large surface area to volume ratio ([@B29]). The SNPs produced in this work were predominantly monodispersed and spherical, with diameters ranging from 1.9-64.9 nm. Our data revealed that the optimal SNP production occurred when a 1.0 mM AgNO ~3~ solution was used during three-five days into the reaction. In this case homogenous SNPs with approximate diameters of 10 nm were detected.

The reducing agent, reaction medium and SNP stabilisation are three key factors in the synthesis of metallic nanoparticles ([@B20]). According to [@B10], reductases in the aqueous extracts of *F. oxysporum* are responsible for the reduction of Ag cations and subsequent SNP production. In addition, the SNP size, spherical form stability and dispersion may be mediated by an interaction between the SNPs and proteins present in the fungal extract ([@B10]). Furthermore, SNPs formed in solutions of complex organic molecules seem to be stabilised by a protective coating. [@B3] reported that humic acid facilitate the generation of SNPs by reducing silver ions, which suggests that nanoparticles can exist in a natural environment. Humic acid appears to stabilise the nanoparticles by coating them and preventing their aggregation into a larger mass of silver ([@B3]). The fungal extract used in this work could also be considered a natural environment. This could explain the difference in the diameters of the agglomerates observed by AFM and TEM. TEM cannot resolve the large agglomerates of SNPs as well as AFM (300 ± 57 nm). Furthermore, the TEM and SEM backscattered images only reveal the silver atomic nuclei.

Previous studies have shown that SNPs exhibit antimicrobial activity against different bacterial species, such as *Shigella dysenteriae* type I, *Staphylococcus aureus*, *Citrobacter* sp., *Escherichia coli*, *Pseudomonas aeruginosa* and *Bacillus subtilis* ([@B24]) and some fungal species, such as *Trichophyton mentagrophytes* and *Candida* spp ([@B17], [@B24]). In our work, we employed two different methods to determine the susceptibility of *Candida* spp and *Cryptococcus* spp. The disc diffusion method resulted in the formation of zones of growth inhibition ranging from 8-15 mm and with the broth microdilution assay we observed MICs of 0.42-1.68 µg/mL.

Similar results were previously reported by [@B24] and [@B16], who tested the effect of SNPs on bacteria and fungi using the same methods. [@B17] observed that the MICs of SNPs against *C. albicans* were lower (2-4 µg/mL) than against *Candida* non- *albicans* (1-25 µg/mL). Recently, [@B27] and [@B31] observed SNPs antifungal activity against several fungi as *Candida* spp, *Aspergillus* spp, *Fusarium* spp *, C. neoformans* and *Sporothrix schenckii* presenting MIC values of 0.12-1 µg/mL.

In our work, we observed similar MIC values for all *Candida* spp and *Cryptococcus* spp tested. However, the MFC values suggest that SNPs are fungistatic to *C. parapsilosis* and *C. krusei* and fungicidal to *C. albicans*, *C. tropicalis*, *C. glabrata* and *Cryptococcus* spp. Recently, [@B22] reported an inhibitory effect of SNPs on *C. albicans* and *C. glabrata* biofilm formation due to reduced cell viability.

Our ultrastructural studies revealed that the yeast cell alterations induced by SNPs treatment largely occur in the cytoplasmic membrane and fungal CW. *C. neoformans* exposed to SNPs exhibit cytoplasmic leakage and apparent SNP retention in the polysaccharide capsule. To our knowledge, this is the first report that demonstrates the action of SNPs on *C. neoformans* cell envelope. Previous work has already demonstrated the ultrastructural effect on *C. albicans* yeast treated with SNPs ([@B18]). SNPs also presented inhibitory activity against *C. albicans* (MIC = 2 µg/mL) and the action may exert the disrupting of the structure of the *C. albicans* CW and cytoplasm membrane and inhibit the normal budding process due to the destruction of the membrane integrity when yeasts were treated with SNPs concentration above MIC value (170 µg/mL) ([@B18]). Our work treated *C. albicans* yeasts with MIC/2 concentration of SNPs, however none ultrastructural alterations was observed by TEM technique. Interestingly, the MIC/2 value of SNPs was able to lead a change of cell envelop ultrastructure of *C. neoformans*.

Several other studies have demonstrated that the cell envelope constitutes the major target of SNP antimicrobial activity. [@B7] also demonstrated that the SNPs can self-assemble and interact with *C. albicans* and *S. aureus* cells, leading to the disintegration of CWs and cytoplasmic membranes and cytoplasm leakage. The effect of SNPs on *S. aureus* growth, morphology and CW integrity was investigated ([@B21]), revealing bacterial growth inhibition, CW damage with peptidoglycan variations and release of muramic acid and accumulation of SNPs in the bacterial membrane at SNP concentrations greater than 8 µg/mL. Membrane disruption by SNPs is likely due to the production of reactive oxygen species (ROS), including free radicals that cause membrane lipid peroxidation. This membrane disruption allows the passage of SNPs into the cytoplasm, which causes subsequent damage of DNA and other phosphorus-containing compounds and impairs the respiratory chain and cell division ([@B29]). Recently, [@B13] showed SNPs possess antifungal effects through apoptosis. The treatment induced in *C. albicans* yeasts an accumulation of ROS, reduction in the mitochondrial membrane potential, phosphatidylserine externalisation, DNA and nuclear fragmentation and the activation of metacaspases.

In mammalian cells, cytotoxicity is related to a loss of cell viability, DNA fragmentation and subsequent apoptosis. Furthermore, the endoplasmic reticulum may play an important role in the response to oxidative stress-induced damage and is quite sensitive to oxidative damage ([@B32]). Interestingly, biogenic SNPs seems to be generally less cyto/genotoxic in vivo compared with chemically synthesised nanoparticles. Furthermore, human cells were found to have a greater resistance to the toxic effects of SNPs in comparison with other organisms ([@B19]).

The antimicrobial effects of SNPs depend on their size and the rate of silver ion release. Smaller-sized particles exhibit greater activity due to their higher surface area to volume ratio ([@B23]). The ionic form of silver has been known for centuries to cure infectious diseases caused by various bacterial species, e.g., *E. coli*, *S. aureus*, *Klebsiella* sp. and *Pseudomonas* sp. ([@B6], [@B29]). SNPs have an advantage over ionic silver because they exhibit reduced toxicity and greater antimicrobial potential ([@B14]). The superior antimicrobial properties of SNPs compared to silver salts are due to the large surface area of the particles, which provides better contact with the microorganisms. In addition, the SNPs release silver ions directly into the bacteria, which enhance bactericidal activity ([@B29]).

Although in vitro and in vivo studies have indicated that SNPs are toxic to mammalian cells and that increased exposure of humans to SNPs entails potential risk, some studies have described broad applications of SNPs in the technological and medical fields ([@B2], [@B5], [@B30]). However these applications remain largely unexplored. The production of SNPs using aqueous extracts of the fungus *F. oxysporum* is a potential candidate for low-cost and environmentally friendly production of stable and uniformly sized SNPs with anticandidal and anticryptococcal activities. In this regard, the results obtained in this work open several avenues of further study, such as purification and biochemical characterisation of reductases produced by *F. oxysporum* or development of an alternative SNP formulation that reduces the toxicity of silver. In addition, the utilisation of silver metal in nanoparticulate form may be a new strategy for the treatment of fungal infection.
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